Analysts' ratings for Pacira BioSciences (NASDAQ:PCRX) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 5 | 1 | 0 | 0 | 0 |
Last 30D | 2 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 2 | 1 | 0 | 0 | 0 |
3M Ago | 1 | 0 | 0 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $47.17, along with a high estimate of $57.00 and a low estimate of $38.00. Experiencing a 2.54% decline, the current average is now lower than the previous average price target of $48.40.
Interpreting Analyst Ratings: A Closer Look
A clear picture of Pacira...
ログインすると全部閲覧できます。
ログイン